Paediatric asthma drug recalled in Canada
This article was originally published in Scrip
Executive Summary
Canadian patients are being advised to check packs of Paladin Labs/Novartis's paediatric prescription asthma drug, Zaditen (ketotifen fumarate), after a lot was found to contain a reduced amount of active ingredient than detailed on its label.